| Literature DB >> 22523490 |
Sermin Genc1, Zeynep Zadeoglulari, Stefan H Fuss, Kursad Genc.
Abstract
Exposure to ambient air pollution is a serious and common public health concern associated with growing morbidity and mortality worldwide. In the last decades, the adverse effects of air pollution on the pulmonary and cardiovascular systems have been well established in a series of major epidemiological and observational studies. In the recent past, air pollution has also been associated with diseases of the central nervous system (CNS), including stroke, Alzheimer's disease, Parkinson's disease, and neurodevelopmental disorders. It has been demonstrated that various components of air pollution, such as nanosized particles, can easily translocate to the CNS where they can activate innate immune responses. Furthermore, systemic inflammation arising from the pulmonary or cardiovascular system can affect CNS health. Despite intense studies on the health effects of ambient air pollution, the underlying molecular mechanisms of susceptibility and disease remain largely elusive. However, emerging evidence suggests that air pollution-induced neuroinflammation, oxidative stress, microglial activation, cerebrovascular dysfunction, and alterations in the blood-brain barrier contribute to CNS pathology. A better understanding of the mediators and mechanisms will enable the development of new strategies to protect individuals at risk and to reduce detrimental effects of air pollution on the nervous system and mental health.Entities:
Year: 2012 PMID: 22523490 PMCID: PMC3317189 DOI: 10.1155/2012/782462
Source DB: PubMed Journal: J Toxicol ISSN: 1687-8191
Figure 1The impact of air pollution on the brain through multiple pathways.
The effects of air pollutants on neuronal and glial cells in vitro.
| Pollutants | Species | Cell type | Assays | Key findings | References |
|---|---|---|---|---|---|
|
| |||||
| DEPs | Rat | VM Neuron-glia | TH immunostaining | DA neurotoxicity |
[ |
| OX-42 immunostaining | Microglial activation | ||||
| Mouse | Microglia | DCFH-DA | Increased microglial ROS | ||
| Microglia | DA uptake | No DEP neurotoxicity | |||
| DEPs + LPS | Rat | VM Neuron-glia | Griess reaction | Increased NO production |
[ |
| Rat | HAPI microglial | TH immunostaining | DA neurotoxicity | ||
| cell line | ELISA | Increased TNF | |||
| DEPs | Rat | Brain capillaries | CM-H2DCFDA | Increased ROS production |
[ |
| ELISA | Increased TNF | ||||
| CAPs | Mouse | BV2 microglial cell line | ELISA | Increased TNF |
[ |
| Western blotting microarray | Upregulated inflammatory genes | ||||
|
| |||||
| Ozone | Rat | Astrocyte | MDA | Increased lipid peroxidation |
[ |
| LDH | Decreased cell viability | ||||
Abbreviations: concentrated ambient particles (CAPs), 2′,7′-dichlorfluorescein-diacetate (DCFH-DA), dopaminergic (DA), diesel exhaust particles (DEPs), enzyme-linked immunosorbent assay (ELISA), interleukin-6 (IL-6), lactate dehydrogenase (LDH), malondialdehyde (MDA) nitric oxide (NO), reactive oxygen species (ROS), tyrosine hydroxylase (TH), tumor necrosis factor alpha (TNFα), ventral mesencephalic (VM).
The effects of air pollutants on the central nervous system in vivo.
| Pollutants | Species | Route of administration | Assays | Key findings and outcome | References |
|---|---|---|---|---|---|
|
| |||||
| Mouse (ApoE−/−) | Inhalation | TH immunostaining | DA neurotoxicity | [ | |
| CAPs | Mouse (ApoE−/−) | Inhalation | EMSA | NF | [ |
| Mouse | Inhalation | EMSA | NF |
[ | |
|
| |||||
| Increased TNF | |||||
| DEPs | Rat | Inhalation | IHC, RT-PCR | Increased HO-1 and COX2 mRNA and protein expression | [ |
| Mouse | Inhalation (w/wo i.p. LTA injection) | Microdialysis/HPLC | Increased glutamate levels Inreased NMDA receptor subunits (NR1, NR2A, and NR2B), and CaMKIV mRNA | [ | |
|
| |||||
| Inhalation (nasal) | EMSA | NF | [ | ||
| Rat | Mice | Inhalation | Open-field test | Decreased locomotor activity | [ |
| Rat | Inhalation/Intratracheal | IBA-1 immunostaining | Microglial activation | ||
| ELISA | Increased TNF |
[ | |||
| qRT-PCR | Increased TNF | ||||
|
| |||||
| ROFA | Rat | In instillation | TBARs | Increased lipid peroxidation |
[ |
|
| |||||
| Open-field test | Decreased exploratory behavior | ||||
| NSCB | Mouse | in instillation (w/wo ip LTA injection) | RT-PCR | Increased TNF | [ |
|
| |||||
| Rat | Inhalation (temporal) | Motor activity test | Decreased motor activity | [ | |
| Rat (ovariectomized) | Inhalation | TH immunostaining | Loss of DA neurons (SN) | [ | |
| Rat | Inhalation | Behavioral tests | Increased freezing behavior Decreased exploratory behavior |
[ | |
| Lipid peroxidation assay | Increased lipid peroxidation | ||||
| Neurodegeneration | |||||
| Electron microscopy | Changes in neurotransmitter levels | ||||
| Ozone | Rat(ovariectomized) | Inhalation | Behavioral tests | Impaired olfactory perception and social recognition memory | [ |
| Rat | Inhalation | Behavioral tests | Impaired memory | [ | |
| Rat | Inhalation | IHC | Increased VEGF, IL-6 and TNF | [ | |
| Rat | Inhalation | IHC | Increased c-Fos expression in different brain regions including NTS | [ | |
Abbreviations: apolipoprotein E (ApoE), calcium/calmodulin-dependent protein kinase type IV(CaMKIV), concentrated ambient particles (CAPs), cyclooxygenase-2 (COX-2), dopaminergic (DA), diesel exhaust particles (DEPs), electrophoretic mobility shift assay (EMSA), enzyme-linked immunosorbent assay (ELISA), heme oxygenase (HO), high-performance liquid chromatography (HPLC), allograft inflammatory factor 1(IBA1), immunohistochemistry (IHC), interleukin-1 alpha (IL-1α), interleukin-1beta (IL-1β), interleukin-6 (IL-6), c-Jun N-terminal kinases (JNK), macrophage inflammatory proteins (MIPs), nanosized carbon black (NSCB), lipoteichoic acid (LTA), nuclear factor kappa B (NFκB), nucleus tractus solitarius (NTS), residual oil fly ash (ROFA), reverse transcription polymerase chain reaction (RT-PCR), substantia nigra (SN), thiobarbituric acid-reactive substances (TBARS), tyrosine hydroxylase (TH), tumor necrosis factor alpha (TNFα), and vascular endothelial growth factor (VEGF).